Initiating on Glanbia With No-Moat Rating, EUR 12 Fair Value Estimate; Share Slightly Undervalued

Business Strategy & Outlook:

Despite its positioning in fast-growing segments, benefiting from secular trends around healthy lifestyle and wellness, the company believes Glanbia’s products are largely commoditized and it assigns the company a no-moat rating. From its humble beginnings as an Irish dairy cooperative, Glanbia has transformed over the past few decades into a global manufacturer of ingredients and sports nutrition, primarily by using whey, a byproduct of milk processing and cheese manufacturing. Acquisitions have served to further diversify the portfolio away from whey-based ingredients and products, with Glanbia also building a sizable position in vitamins and mineral premix, which has contributed to the accelerated growth of the segment. Its cheese operations, however, either wholly owned or as joint ventures, still account for a large share of revenue and it is believed to have constituted a distraction for management from the higher-value-added parts of the portfolio. The performance nutrition segment, which includes brands such as Optimum Nutrition, BSN, and SlimFast, has been struggling over the past five years, with diminishing pricing power and organic growth rates that have significantly lagged the market, translating into share loss to new and nimble players. Company believes the acquisition in late 2018 of the SlimFast brand has done little to rejuvenate the portfolio and improve its growth prospects, and it surmises that the brand’s deteriorating equity has added more pressure to already increasing customer acquisition costs. Company believes the nutritional solutions segment to be the most valuable for Glanbia, delivering above-average growth rates and margin. The company’s leading portfolio of protein and vitamin and mineral premix ingredients and solutions creates a compelling proposition for customers in the food, beverage, and supplements space. Although the management don’t believe the products to be differentiated—Glanbia’s research and development spend of below 1% is among the lowest in the ingredients peer group— do reckon that Glanbia’s credentials in the space are likely to continue to lead to outperformance for the segment versus the market over the midterm

Financial Strengths:

Glanbia is in good financial health. Net debt levels are manageable, with a net debt/adjusted 2021 EBITDA ratio of 1.8 times, in line with previous years, and available banking facilities totaling EUR 1.2 billion. Company forecasts acquisition spending of around EUR 100 million per year for the next five years, in line with historical averages and keeping with the company’s strategy of expanding its footprint in the ingredients market. The company expects these acquisitions to be largely financed from free cash flow generation, which will enable Glanbia to maintain its solid financial position. In the five years leading up to 2021, capital spending averaged only 2% of sales, making Glanbia one of the most capital-light companies in the ingredients industry. The company employs a progressive dividend policy, targeting a dividend payout ratio of 25%-35% of adjusted earnings per share, which are viewed as manageable.

Bulls Say:

In the nutritional solutions segment, Glanbia is well positioned to benefit from growing consumer trends regarding healthier lifestyles, wellbeing, and increased immunity.
The sale of its 40% holding in the Glanbia Ireland joint venture further enables Glanbia to focus and reinvest in its higher-value-added segments.
Glanbia’s portfolio expansion into vitamin and mineral premix has enabled the company to create a compelling proposition for supplement and on-the-go snacking manufacturers, and expects these applications to continue to drive the above-average growth of the segment.

Company Description:

Meaning “pure food” in Irish, Glanbia is a global ingredient and branded performance nutrition manufacturer present in 32 countries with sales in 130 countries and over 7,500 employees. Originating in Ireland in the 1960s in the dairy processing industry, predecessor companies were initially listed in 1988 before Glanbia came into being in 1999. Production facilities are concentrated in Ireland, the U.K., Germany, the U.S., and China. Glanbia processes over 6 billion liters of milk annually and is also a major producer of U.S. cheddar cheese. Glanbia generates more than 80% of its revenue in the U.S.

(Source: Morningstar)

DISCLAIMER for General Advice: (This document is for general advice only).

This document is provided by Laverne Securities Pty Ltd T/as Laverne Investing. Laverne Securities Pty Ltd, CAR 001269781 of Laverne Capital Pty Ltd AFSL No. 482937.

The material in this document may contain general advice or recommendations which, while believed to be accurate at the time of publication, are not appropriate for all persons or accounts. This document does not purport to contain all the information that a prospective investor may require. The material contained in this document does not take into consideration an investor’s objectives, financial situation or needs. Before acting on the advice, investors should consider the appropriateness of the advice, having regard to the investor’s objectives, financial situation, and needs. The material contained in this document is for sales purposes. The material contained in this document is for information purposes only and is not an offer, solicitation or recommendation with respect to the subscription for, purchase or sale of securities or financial products and neither or anything in it shall form the basis of any contract or commitment. This document should not be regarded by recipients as a substitute for the exercise of their own judgment and recipients should seek independent advice.

The material in this document has been obtained from sources believed to be true but neither Laverne and Banyan Tree nor its associates make any recommendation or warranty concerning the accuracy or reliability or completeness of the information or the performance of the companies referred to in this document. Past performance is not indicative of future performance. Any opinions and or recommendations expressed in this material are subject to change without notice and, Laverne and Banyan Tree are not under any obligation to update or keep current the information contained herein. References made to third parties are based on information believed to be reliable but are not guaranteed as being accurate.

Laverne and Banyan Tree and its respective officers may have an interest in the securities or derivatives of any entities referred to in this material. Laverne and Banyan Tree do and seek to do business with companies that are the subject of its research reports. The analyst(s) hereby certify that all the views expressed in this report accurately reflect their personal views about the subject investment theme and/or company securities.

Although every attempt has been made to verify the accuracy of the information contained in the document, liability for any errors or omissions (except any statutory liability which cannot be excluded) is specifically excluded by Laverne and Banyan Tree, its associates, officers, directors, employees, and agents. Except for any liability which cannot be excluded, Laverne and Banyan Tree, its directors, employees and agents accept no liability or responsibility for any loss or damage of any kind, direct or indirect, arising out of the use of all or any part of this material. Recipients of this document agree in advance that Laverne and Banyan Tree are not liable to recipients in any matters whatsoever otherwise; recipients should disregard, destroy or delete this document. All information is correct at the time of publication. Laverne and Banyan Tree do not guarantee reliability and accuracy of the material contained in this document and are not liable for any unintentional errors in the document.

The securities of any company(ies) mentioned in this document may not be eligible for sale in all jurisdictions or to all categories of investors. This document is provided to the recipient only and is not to be distributed to third parties without the prior consent of Laverne and Banyan Tree.